Teva's generic of Uceris® Extended-Release Tablets: Budesonide Extended-Release Tablets
Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire
Corticosteroid Budesonide 0.5 mg / 2 mL Inhalation Suspension Ampule 2 mL – Caring Med
BUY Budesonide - (Enteric Coated) (Budesonide) 3 mg/1 Teva Pharmaceuticals USA, Inc.
Research roundup: Budesonide-formoterol used as needed to prevent asthma exacerbations: a trial reflecting real-world practice | Let's Talk Respiratory - Let's Talk Respiratory
Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study - Gastroenterology
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease | SpringerLink
Teva Pharmaceutical Industries, Author at Pharmaceutical Processing World